FAKTOR-OPTIONSSCHEIN - ORION B | Market Closed - Börse Stuttgart 19:49:11 07/06/2024 BST | ||
| 12.18 EUR | +0.58% |
|
| Current month | +6.94% | ||
| 1 month | +15.12% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 12.18 | +0.58% |
| 06/06/24 | 12.11 | -2.18% |
| 05/06/24 | 12.38 | +0.81% |
| 04/06/24 | 12.28 | +3.80% |
| 03/06/24 | 11.83 | +3.86% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 07:49 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG0HKG |
| ISIN | DE000MG0HKG8 |
| Date issued | 20/03/2024 |
| Strike | 19.42 € |
| Maturity | Unlimited |
| Parity | 1.6 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.39 € |
|---|---|
| Lowest since issue | 8.46 € |
| Spread | 0.13 € |
| Spread % | 1.06% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.94
EUR
Average target price
39
EUR
Spread / Average Target
+0.15%
- Stock Market
- Certificates
- Certificat